The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1733
ISSUE1733
Med Lett Drugs Ther. 2025 Jul 21;67(1733):120 doi:10.58347/tml.2025.1733i
Disclosures
Objective(s)
In the recent Medical Letter article on Drugs for Chronic Heart Failure (2025: 67:81), the paragraph on adverse effects of SGLT2 inhibitors should have stated that these drugs can cause ketoacidosis, which can be fatal, especially in patients with type 1 diabetes.
© The Medical Letter, Inc. All Rights Reserved.
The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and
complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any
damage resulting from any error, inaccuracy, or omission.
This article has been freely provided.
Previous article